Preclinical studies of ZG19018, a novel irreversible covalent inhibitor of KRAS G12C, for the treatment of advanced nonsmall cell lung cancer and other solid tumors

被引：0
|
作者：
Zhu, Bing
Cui, Dawei
Liu, Ruifeng
Feng, Weidong
Sheng, Zelin
Lv, Binhua
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2790
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2790
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy of JS']JSI-1187 or VIC-1911 in combination with KRAS G12C inhibitors for the treatment of KRAS G12C-mutated non-small cell lung cancer and colorectal cancer
    Zhang, Lei
    Li, Ao
    Jian, Shanzhong
    Du, Chengyi
    Zhu, Wan
    Tao, Yue
    Wang, Meiwei
    Xu, Wen
    Hao, Wenshan
    Paradiso, Linda
    Myers, Thomas
    Koya, Keizo
    Zhang, Jintao
    CANCER RESEARCH, 2023, 83 (07)
  • [32] KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Patients with Colorectal Cancer (CRC) and Other Solid Tumors Harboring a KRAS G12C Mutation
    Johnson, M. L.
    Ou, S. H. I.
    Barve, M.
    Rybkin, I. I.
    Papadopoulos, K. P.
    Leal, T. A.
    Velastegui, K.
    Christensen, J. G.
    Kheoh, T.
    Chao, R. C.
    Weiss, J.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S2 - S2
  • [33] CodeBreak 200: A phase III multicenter study of sotorasib (AMG 510), a KRAS(G12C) inhibitor, versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC) harboring KRAS p.G12C mutation
    Reck, M.
    Spira, A.
    Besse, B.
    Wolf, J.
    Skoulidis, F.
    Borghaei, H.
    Goto, K.
    Park, K.
    Griesinger, F.
    Felip, E.
    Boyer, M.
    Barrios, C. H.
    Goss, G.
    Yang, H.
    Obiozor, C.
    Ramalingam, S. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S894 - S895
  • [34] A phase 1/2 study of VS-6766 (RAF/MEK clamp) in combination with sotorasib (G12C inhibitor) in patients with KRAS G12C mutant non-small cell lung cancer (NSCLC) (RAMP 203).
    Govindan, Ramaswamy
    Awad, Mark M.
    Gadgeel, Shirish M.
    Pachter, Jonathan A.
    Patrick, Gloria
    Denis, Louis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] A retrospective study of the prevalence and clinical outcomes of KRAS G12C mutated advanced non-small cell lung cancer (NSCLC) in Australian patients (pts)
    Markman, B.
    Solomon, B.
    Nott, L. M.
    Roberts-Thomson, R.
    Hughes, B.
    Pavlakis, N.
    Davis, A.
    Brown, L. J.
    Parakh, S.
    Brungs, D.
    Bowyer, S. E.
    Nordman, I.
    Jennens, R.
    Warburton, L.
    Harris, S. J.
    Samuel, E.
    Ramanujam, S.
    Wang, A.
    Dumas, M.
    Gard, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1700 - S1700
  • [36] Sotorasib vs Adagrasib: Matching-adjusted Indirect Comparison in Prior Treated KRAS G12C Advanced Non-Small Cell Lung Cancer
    Chopra, D.
    Waterhouse, D. M.
    Sylvester, B.
    Jamotte, A.
    Stollenwerk, B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S647 - S648
  • [37] KRAS G12C Inhibitor IBI351 In Patients (pts) with Advanced Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Pivotal Phase 2 Study
    Zhou, Q.
    Meng, X.
    Sun, L.
    Huang, D.
    Yang, N.
    Yu, Y.
    Zhao, M.
    Zhuang, W.
    Hu, Y.
    Pan, Y.
    Sun, M.
    Shan, J.
    Guo, R.
    Chu, Q.
    Xu, C.
    Lin, J.
    Huang, J.
    Huang, M.
    Zhang, S.
    Wu, Y. L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S42 - S42
  • [38] A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
    Spira, A.
    Riely, G.
    Lawler, W.
    Shum, M.
    Socinski, M.
    Yanagihara, R.
    Roshan, S.
    Kheoh, T.
    Christensen, J.
    Chao, R.
    Janne, P.
    Garassino, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S695 - S696
  • [39] The sooner, the better: early clearance of plasma circulating tumor DNA in patients with advanced KRAS G12C mutant non-small cell lung cancer
    Garcia-Pardo, Miguel
    Garrido, Pilar
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (02) : 215 - 219
  • [40] KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study
    Frost, Matilde Grupe
    Jensen, Kristoffer Jarlov
    Gotfredsen, Ditte Resendal
    Sorensen, Anne Mette Skov
    Ankarfeldt, Mikkel Zollner
    Louie, Karly S.
    Sroczynski, Nicholas
    Jakobsen, Erik
    Andersen, Jon Lykkegaard
    Jimenez-Solem, Espen
    Petersen, Tonny Studsgaard
    LUNG CANCER, 2023, 178 : 172 - 182
12345